These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 14600579)

  • 1. Rates and risk factors for condition-specific hospitalizations in HIV-infected and uninfected women.
    Gardner LI; Klein RS; Szczech LA; Phelps RM; Tashima K; Rompalo AM; Schuman P; Sadek RF; Tong TC; Greenberg A; Holmberg SD;
    J Acquir Immune Defic Syndr; 2003 Nov; 34(3):320-30. PubMed ID: 14600579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hospitalization rates differ by hepatitis C satus in an urban HIV cohort.
    Gebo KA; Diener-West M; Moore RD
    J Acquir Immune Defic Syndr; 2003 Oct; 34(2):165-73. PubMed ID: 14526205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rates of hospitalizations and associated diagnoses in a large multisite cohort of HIV patients in the United States, 1994-2005.
    Buchacz K; Baker RK; Moorman AC; Richardson JT; Wood KC; Holmberg SD; Brooks JT;
    AIDS; 2008 Jul; 22(11):1345-54. PubMed ID: 18580614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C virus coinfection and HIV load, CD4+ cell percentage, and clinical progression to AIDS or death among HIV-infected women: Women and Infants Transmission Study.
    Hershow RC; O'Driscoll PT; Handelsman E; Pitt J; Hillyer G; Serchuck L; Lu M; Chen KT; Yawetz S; Pacheco S; Davenny K; Adeniyi-Jones S; Thomas DL
    Clin Infect Dis; 2005 Mar; 40(6):859-67. PubMed ID: 15736020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gender and hospitalization patterns among HIV-infected drug users before and after the availability of highly active antiretroviral therapy.
    Floris-Moore M; Lo Y; Klein RS; Budner N; Gourevitch MN; Moskaleva G; Schoenbaum EE
    J Acquir Immune Defic Syndr; 2003 Nov; 34(3):331-7. PubMed ID: 14600580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hospitalizations of pregnant HIV-infected women in the USA prior to and during the era of HAART, 1994-2003.
    Kourtis AP; Bansil P; McPheeters M; Meikle SF; Posner SF; Jamieson DJ
    AIDS; 2006 Sep; 20(14):1823-31. PubMed ID: 16954723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hospitalization in HIV in Chicago.
    Sherer R; Pulvirenti J; Stieglitz K; Narra J; Jasek J; Green L; Moore B; Shott S; Cohen M
    J Int Assoc Physicians AIDS Care (Chic); 2002; 1(1):26-33. PubMed ID: 12942666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of diagnoses in hospital admissions in a multistate cohort of HIV-positive adults in 2001.
    Betz ME; Gebo KA; Barber E; Sklar P; Fleishman JA; Reilly ED; Christopher Mathews W;
    Med Care; 2005 Sep; 43(9 Suppl):III3-14. PubMed ID: 16116304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in hospitalizations of pregnant HIV-infected women in the United States: 2004 through 2011.
    Ewing AC; Datwani HM; Flowers LM; Ellington SR; Jamieson DJ; Kourtis AP
    Am J Obstet Gynecol; 2016 Oct; 215(4):499.e1-8. PubMed ID: 27263995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disparities in prevalence of key chronic diseases by gender and race/ethnicity among antiretroviral-treated HIV-infected adults in the US.
    Buchacz K; Baker RK; Palella FJ; Shaw L; Patel P; Lichtenstein KA; Chmiel JS; Vellozzi C; Debes R; Henry K; Overton ET; Bush TJ; Tedaldi E; Carpenter C; Mayer KH; Brooks JT;
    Antivir Ther; 2013; 18(1):65-75. PubMed ID: 23111762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Herpes zoster in women with and at risk for HIV: data from the Women's Interagency HIV Study.
    Glesby MJ; Hoover DR; Tan T; Shi Q; Gao W; French AL; Maurer T; Young M; Dehovitz J; Ru J; Anastos K
    J Acquir Immune Defic Syndr; 2004 Dec; 37(5):1604-9. PubMed ID: 15577417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in HIV-related hospitalizations during the HAART era in an inner-city hospital.
    Pulvirenti J; Muppidi U; Glowacki R; Cristofano M; Baker L
    AIDS Read; 2007 Aug; 17(8):390-4, 397-401. PubMed ID: 17717882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. End-stage renal disease among HIV-infected adults in North America.
    Abraham AG; Althoff KN; Jing Y; Estrella MM; Kitahata MM; Wester CW; Bosch RJ; Crane H; Eron J; Gill MJ; Horberg MA; Justice AC; Klein M; Mayor AM; Moore RD; Palella FJ; Parikh CR; Silverberg MJ; Golub ET; Jacobson LP; Napravnik S; Lucas GM;
    Clin Infect Dis; 2015 Mar; 60(6):941-9. PubMed ID: 25409471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroprevalence and risk factors of hepatitis B, hepatitis C, and human cytomegalovirus among HIV-infected and high-risk uninfected adolescents: findings of the REACH Study. Adolescent Medicine HIV/AIDS Research Network.
    Holland CA; Ma Y; Moscicki B; Durako SJ; Levin L; Wilson CM
    Sex Transm Dis; 2000 May; 27(5):296-303. PubMed ID: 10821605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hospitalization rates in an urban cohort after the introduction of highly active antiretroviral therapy.
    Gebo KA; Diener-West M; Moore RD
    J Acquir Immune Defic Syndr; 2001 Jun; 27(2):143-52. PubMed ID: 11404536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hospitalization for pneumonia among individuals with and without HIV infection, 1995-2007: a Danish population-based, nationwide cohort study.
    Sogaard OS; Lohse N; Gerstoft J; Kronborg G; Ostergaard L; Pedersen C; Pedersen G; Sørensen HT; Obel N
    Clin Infect Dis; 2008 Nov; 47(10):1345-53. PubMed ID: 18834317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hospitalizations of pregnant HIV-infected women in the United States in the era of highly active antiretroviral therapy (HAART).
    Bansil P; Jamieson DJ; Posner SF; Kourtis AP
    J Womens Health (Larchmt); 2007 Mar; 16(2):159-62. PubMed ID: 17388731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fracture incidence in HIV-infected women: results from the Women's Interagency HIV Study.
    Yin MT; Shi Q; Hoover DR; Anastos K; Sharma A; Young M; Levine A; Cohen MH; Shane E; Golub ET; Tien PC
    AIDS; 2010 Nov; 24(17):2679-86. PubMed ID: 20859192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of hepatitis C infection on progression of HIV disease and early response to initial antiretroviral therapy.
    Sullivan PS; Hanson DL; Teshale EH; Wotring LL; Brooks JT
    AIDS; 2006 May; 20(8):1171-9. PubMed ID: 16691069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective cohort study of immunologic and virologic outcomes in patients with HIV/AIDS and hepatitis virus co-infection in Jos, Nigeria.
    lsa SE; Gwamzhi LN; Akolo C; Giyan J
    Niger J Med; 2010; 19(3):279-85. PubMed ID: 20845631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.